Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43)

Por Schrijnders, Dennis, Hartog, Laura C., Kleefstra, Nanne, Groenier, Klaas H., Landman, Gijs W. D., Bilo, Henk J. G.
Publicado no PLoS One (2016)

Differences Between Patients With Type 2 Diabetes Mellitus Interested and Uninterested in the Use of a Patient Platform (e-VitaDM-2/ZODIAC-41)

Por Roelofsen, Yvonne, Hendriks, Steven H., Sieverink, Floor, Landman, Gijs W. D., Groenier, Klaas H., Bilo, Henk J. G., Kleefstra, Nanne
Publicado no J Diabetes Sci Technol (2014)

Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized...

Por Hortensius, Johanna, Kleefstra, Nanne, Landman, Gijs W. D., Houweling, Bas T., Groenier, Klaas H., van der Bijl, Jaap J., Bilo, Henk
Publicado no BMC Res Notes (2018)

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16

Por Landman, Gijs W.D., Kleefstra, Nanne, van Hateren, Kornelis J.J., Groenier, Klaas H., Gans, Rijk O.B., Bilo, Henk J.G.
Publicado em 2010

Health-Related Quality of Life and Mortality in a General and Elderly Population of Patients With Type 2 Diabetes (ZODIAC-18)

Por Landman, Gijs W.D., van Hateren, Kornelis J.J., Kleefstra, Nanne, Groenier, Klaas H., Gans, Rijk O.B., Bilo, Henk J.G.
Publicado em 2010

Plasma COOH-Terminal Proendothelin-1: A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)

Por Drion, Iefke, Kleefstra, Nanne, Landman, Gijs W.D., Alkhalaf, Alaa, Struck, Joachim, Groenier, Klaas H., Bakker, Stephan J.L., Bilo, Henk J.G.
Publicado em 2012

Familial Aggregation between the 14(th) and 21(st) Century and Type 2 Diabetes Risk in an Isolated Dutch Population

Por de Visser, Kees L., Landman, Gijs W. D., Meyboom-de Jong, Betty, de Visser, Wim, te Meerman, Gerard J., Bilo, Henk J. G.
Publicado no PLoS One (2015)

Sex differences in survival of patients with type 2 diabetes in primary care (ZODIAC-50)

Por Hendriks, Steven H, van Hateren, Kornelis J J, Groenier, Klaas H, Landman, Gijs W D, Maas, Angela H E M, Bilo, Henk J G, Kleefstra, Nanne
Publicado no BMJ Open (2017)

Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49)

Por Schrijnders, Dennis, Hendriks, Steven H., Kleefstra, Nanne, Vissers, Pauline A. J., Johnson, Jeffrey A., de Bock, Geertruida H., Bilo, Henk J. G., Landman, Gijs W. D.
Publicado no PLoS One (2018)

The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)

Por van Hateren, Kornelis J. J., Landman, Gijs W. D., Kleefstra, Nanne, Logtenberg, Susan J. J., Groenier, Klaas H., Kamper, Adriaan M., Houweling, Sebastiaan T., Bilo, Henk J. G.
Publicado em 2009

Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC‐39)

Por Schrijnders, Dennis, Wever, Raiza, Kleefstra, Nanne, Houweling, Sebastiaan T., van Hateren, Kornelis J. J., de Bock, Geertruida H., Bilo, Henk J. G., Groenier, Klaas H., Landman, Gijs W. D.
Publicado no Diabetes Obes Metab (2016)

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

Por Schrijnders, Dennis, de Bock, Geertruida H., Houweling, Sebastiaan T., van Hateren, Kornelis J. J., Groenier, Klaas H., Johnson, Jeffrey A., Bilo, Henk J. G., Kleefstra, Nanne, Landman, Gijs W. D.
Publicado no BMC Cancer (2017)

Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56)

Por Hendriks, Steven H, Schrijnders, Dennis, van Hateren, Kornelis JJ, Groenier, Klaas H, Siesling, Sabine, Maas, Angela H E M, Landman, Gijs W D, Bilo, Henk J G, Kleefstra, N
Publicado no BMJ Open (2018)

Life Expectancy in a Large Cohort of Type 2 Diabetes Patients Treated in Primary Care (ZODIAC-10)

Por Lutgers, Helen L., Gerrits, Esther G., Sluiter, Wim J., Ubink-Veltmaat, Lielith J., Landman, Gijs W. D., Links, Thera P., Gans, Reinold O. B., Smit, Andries J., Bilo, Henk J. G.
Publicado em 2009

Comparison of Methods for Renal Risk Prediction in Patients with Type 2 Diabetes (ZODIAC-36)

Por Riphagen, Ineke J., Kleefstra, Nanne, Drion, Iefke, Alkhalaf, Alaa, van Diepen, Merel, Cao, Qi, Groenier, Klaas H., Landman, Gijs W. D., Navis, Gerjan, Bilo, Henk J. G., Bakker, Stephan J. L.
Publicado no PLoS One (2015)

Safety and Efficacy of Gliclazide as Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Trials

Por Landman, Gijs W. D., de Bock, Geertruide H., van Hateren, Kornelis J. J., van Dijk, Peter R., Groenier, Klaas H., Gans, Rijk O. B., Houweling, Sebastiaan T., Bilo, Henk J. G., Kleefstra, Nanne
Publicado em 2014

The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)

Por van Hateren, Kornelis J.J., Landman, Gijs W.D., Kleefstra, Nanne, Groenier, Klaas H., Struck, Joachim, Navis, Gerjan J., Bakker, Stephan J.L., Houweling, Sebastiaan T., van der Meer, Klaas, Bilo, Henk J.G.
Publicado em 2013

Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)

Por van Hateren, Kornelis J. J., Landman, Gijs W. D., Arnold, Jarinke F. H., Joosten, Hanneke, Groenier, Klaas H., Navis, Gerjan J., Sparwasser, Andrea, Bakker, Stephan J. L., Bilo, Henk J. G., Kleefstra, Nanne
Publicado no PLoS One (2015)

Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28)

Por Gerrits, Esther G., Alkhalaf, Alaa, Landman, Gijs W. D., van Hateren, Kornelis J. J., Groenier, Klaas H., Struck, Joachim, Schulte, Janin, Gans, Reinold O. B., Bakker, Stephan J. L., Kleefstra, Nanne, Bilo, Henk J. G.
Publicado em 2014

Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis

Por Kovesdy, Csaba P, Matsushita, Kunihiro, Sang, Yingying, Brunskill, Nigel J, Carrero, Juan J, Chodick, Gabriel, Hasegawa, Takeshi, Heerspink, Hiddo L, Hirayama, Atsushi, Landman, Gijs W D, Levin, Adeera, Nitsch, Dorothea, Wheeler, David C, Coresh, Josef, Hallan, Stein I, Shalev, Varda, Grams, Morgan E
Publicado no Eur Heart J (2018)